Results 1 to 10 of about 33,549 (305)

Left Ventricular Assist Device Support Complicates the Exercise Physiology of Oxygen Transport and Uptake in Heart Failure [PDF]

Cardiac Failure Review, 2019
Low-output forward flow and impaired maximal exercise oxygen uptake (VO2 max) are hallmarks of patients in advanced heart failure. The continuous-flow left ventricular assist device is a cutting-edge therapy proven to increase forward flow, yet this ...
Erik H Van Iterson
doaj   +2 more sources

Echocardiography in left ventricular assist device

Heart Views, 2010
LVAD = Left Ventricular Assist Device; LV = Left Ventricle; LA = Left Atrium; AO = Aorta.
Sherif M Helmy, Alia Albinali, Rachel Hajar   +2 more
doaj   +3 more sources

Experience with left ventricular assist device usage in the treatment of end-stage heart failure [PDF]

Кардіохірургія та інтервенційна кардіологія, 2017
Heart failure potentially developing in most of heart diseases is a progressive process associated with high morbidity and mortality. Almost 3/4 of patients die within five years after first hospitalization because of heart failure.
B.M. Todurov, G.I. Kovtun, I.M. Kuzmich, M.V. Goncharenko, A.M. Druzhyna, A.O. Shpachuk, O.M. Postupalsky, S.O. Sheludko, S.M. Sudakevych, O.V. Stanyshevskyi, A.Yu. Melnyk   +10 more
doaj   +1 more source

Left Ventricular Assist Devices [PDF]

Health Affairs, 2015
The left ventricular assist device (LVAD) has become an established treatment option for patients with refractory heart failure. Many of these patients experience chronic kidney disease (CKD) due to chronic cardiorenal syndrome type II, which is often alleviated quickly following LVAD implantation.
Kory Lavine, Susan Joseph
  +8 more sources

Early planned institution of biventricular mechanical circulatory support results in improved outcomes compared with delayed conversion of a left ventricular assist device to a biventricular assist device

Journal of Thoracic and Cardiovascular Surgery, 2009
ObjectiveIt is generally accepted that patients who require biventricular assist device support have poorer outcomes than those requiring isolated left ventricular assist device support.
William Hiesinger, Elliott D Kozin, Y Joseph Woo   +2 more
exaly   +2 more sources

Clinical outcome in patients with end-stage heart failure who underwent continuous-flow left ventricular assist devices in a single center [PDF]

The Korean Journal of Internal Medicine, 2022
Background/Aims The continuous flow left ventricular assist device (cf-LVAD) has improved the survival of chronic end-stage heart failure (HF) patients.
Yoonjee Park, Darae Kim, Jeong Hoon Yang, Yang Hyun Cho, Jin-Oh Choi, Eun-Seok Jeon   +5 more
doaj   +1 more source

Percutaneous left ventricular assist devices in refractory cardiac arrest: The role of chest compressions

Resuscitation Plus, 2023
Background: Recent studies describe an emerging role for percutaneous left ventricular assist devices such as Impella CP® as rescue therapy for refractory cardiac arrest.
Adam L. Gottula, Brendan M. McCracken, Takahiro Nakashima, Nicholas L. Greer, Traci A. Cramer, Nadia R. Sutton, Kevin R. Ward, Robert W. Neumar, Mohamad Hakam Tiba, Cindy H. Hsu   +9 more
doaj   +1 more source

Right and left ventricular assist devices are an option for bridge to heart transplantCentral MessagePerspective

JTCVS Open, 2022
Background: Patients with a left ventricular assist device with right ventricular failure are prioritized on the heart transplant waitlist; however, their post-transplant survival is less well characterized.
Yaron D. Barac, MD, PhD, Ronen Toledano, MD, Oliver K. Jawitz, MD, Jacob N. Schroder, MD, Mani A. Daneshmand, MD, Chetan B. Patel, MD, Dan Aravot, MD, Carmelo A. Milano, MD   +7 more
doaj   +1 more source

Surgical outcomes of bridge-to-bridge therapy with extracorporeal left ventricular assist device for acute myocardial infarction in cardiogenic shock

BMC Cardiovascular Disorders, 2022
Background Extracorporeal left ventricular assist device is often required for acute myocardial infarction patients in cardiogenic shock when temporary mechanical circulatory support fails to provide hemodynamic stabilization.
Chiho Tokunaga, Atsushi Iguchi, Hiroyuki Nakajima, Fumiya Chubachi, Yuto Hori, Akitoshi Takazawa, Jun Hayashi, Toshihisa Asakura, Akihiro Yoshitake   +8 more
doaj   +1 more source

Left ventricular assist devices [PDF]

Journal of the Intensive Care Society, 2020
Background There is a growing population of patients in the UK with advanced heart failure who are receiving a left ventricular assist device (LVAD) as a bridge to transplant. This is due to the plateauing number of heart transplantations and the increasing evidence of the effectiveness of these devices.
openaire   +2 more sources